Ardelyx (ARDX) Non-Current Debt (2018 - 2026)
Ardelyx (ARDX) posted Non-Current Debt of $203.5 million for Q1 2026, little changed on a QoQ basis from $202.8 million in Q4 2025, and up 34.51% year-over-year from $151.3 million in Q1 2025.
Ardelyx (ARDX) Non-Current Debt (2018 - 2026) Analysis & Trends
Ardelyx's Non-Current Debt history runs 9 years deep, the most recent figure standing at $203.5 million for Q1 2026.
- Quarterly Non-Current Debt rose 34.51% year-over-year to $203.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.5 million (up 34.51% YoY) and the FY2025 annual result came in at $202.8 million, up 34.46% from the prior year.
- Non-Current Debt was $203.5 million for Q1 2026 at Ardelyx, roughly flat from $202.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $203.5 million in Q1 2026 and bottomed at $26.1 million in Q1 2022.
- A 5-year average of $112.1 million and a median of $100.5 million in 2024 frame the typical range for Non-Current Debt.
- Peak annual rise in Non-Current Debt reached 277.43% in 2022, while the deepest fall reached 23.9% in 2022.
- Ardelyx's Non-Current Debt stood at $26.5 million in 2022, then surged by 87.72% to $49.8 million in 2023, then surged by 202.78% to $150.9 million in 2024, then surged by 34.46% to $202.8 million in 2025, then rose by 0.34% to $203.5 million in 2026.
- Business Quant data shows ARDX's Non-Current Debt at $203.5 million in Q1 2026, $202.8 million in Q4 2025, and $202.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 203.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.52 Mn |
| Dec 31, 2025 | 202.83 Mn |
| Sep 30, 2025 | 202.14 Mn |
| Jun 30, 2025 | 201.45 Mn |
| Mar 31, 2025 | 151.30 Mn |
| Dec 31, 2024 | 150.85 Mn |
| Sep 30, 2024 | 100.71 Mn |
| Jun 30, 2024 | 100.25 Mn |
| Mar 31, 2024 | 99.83 Mn |
| Dec 31, 2023 | 49.82 Mn |
| Sep 30, 2023 | 27.23 Mn |
| Sep 30, 2022 | 26.54 Mn |
| Jun 30, 2022 | 26.37 Mn |
| Mar 31, 2022 | 26.14 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 15.13 Mn |
| Mar 31, 2021 | 34.35 Mn |
| Dec 31, 2020 | 46.62 Mn |
| Sep 30, 2020 | 50.68 Mn |
| Jun 30, 2020 | 36.74 Mn |